Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R Mayo, Daniel J Trepanier, Robert T Foster, Philippe Gallay and Daren R Ure
Journal of Pharmacology and Experimental Therapeutics August 12, 2019, jpet.119.261099; DOI: https://doi.org/10.1124/jpet.119.261099
